PFS
BLFS icon

Prospera Financial Services’s BioLife Solutions BLFS Stock Holding History

Prospera Financial Services’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-91
Closed -$1K – 913
2022
Q2 		$1K Buy
+91
New +$1.33K ﹤0.01% 1588

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prospera Financial Services's BLFS Position: Q3 2022 in Review

Prospera Financial Services sold out of BioLife Solutions (BLFS) in Q3 2022, closing a stake of 91 shares — an estimated $1K sold.

Prospera Financial Services first reported a position in BLFS in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 174 funds tracked by Wall St. Rank hold BLFS as of Q3 2022.

  • Prospera Financial Services reported no remaining BioLife Solutions position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 91 BioLife Solutions shares in Q3 2022, an estimated $1K.
  • Prospera Financial Services first reported a position in BioLife Solutions in Q2 2022 and held it in 1 quarter.
  • Prospera Financial Services's BioLife Solutions position peaked at $1K in Q2 2022.
  • 174 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.